We use necessary cookies to make our website work. We also use optional statistical, functional and marketing cookies that you can choose to decline in your preference setting.
23rd Annual Biotech in Europe Forum - Sachs Associates
Bioxodes' CEO March Dechamps presents at the 23rd Annual Biotech in Europe Forum for Global Parntering & Investment, organised by Sachs Associates
CEO Marc Dechamps will present groundbreaking developments in Bioxodes' journey towards revolutionizing stroke care.
Our lead candidate Ir-CPI has a distinctive mode of action which provides a dual benefit by preventing blood clots, minimizing bleeding risks, and inhibiting neuroinflammatory events linked to intracerebral hemorrhage.